Spots Global Cancer Trial Database for macular edema secondary to branch retinal vein occlusion
Every month we try and update this database with for macular edema secondary to branch retinal vein occlusion cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) | NCT01976338 | Macular Edema S... | Ranibizumab 0.5... Sham injection | 18 Years - | Novartis | |
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) | NCT01976338 | Macular Edema S... | Ranibizumab 0.5... Sham injection | 18 Years - | Novartis | |
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO) | NCT01976338 | Macular Edema S... | Ranibizumab 0.5... Sham injection | 18 Years - | Novartis |